Company Filing History:
Years Active: 2005
Title: Spencer R Jeffrey: Innovator in Protease Inhibitors
Introduction
Spencer R Jeffrey is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as protease inhibitors. His work has implications for cancer treatment and the prevention of thromboembolic disorders.
Latest Patents
Spencer R Jeffrey holds a patent for his invention titled "(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors." This patent describes novel compounds that include a bicyclic heterocyclic ring structure and an aryl or heteroaryl group. The compounds are designed to inhibit serine proteases, including Urokinase (uPA), Factor Xa (FXa), and Factor VIIa (FVIIa). These compounds have potential applications as anti-cancer agents and anticoagulants.
Career Highlights
Jeffrey is associated with Axys Pharmaceuticals, Inc., where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approach to drug design has led to the creation of compounds that address critical health issues.
Collaborations
Some of his notable coworkers include Darin A Allen and Jason M Hataye, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Spencer R Jeffrey's contributions to the field of protease inhibitors highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.